Heart Surgery Scandal Widens: More Hospitals Under Scrutiny as Government Considers Stricter Doctor Regulations
Translated from German, summarized and contextualized by DistantNews.
TLDR
- An investigation into a heart surgery scandal at Zurich University Hospital (USZ) has revealed a high mortality rate and the misuse of novel implants.
- The scandal, which cost USZ 2 million Swiss francs to investigate, has now expanded to include other hospitals, including Bern's Inselspital, where a device called Cardioband was used 36 times.
- Concerns are rising about potential financial ties between the implicated surgeon, Francesco Maisano, and medical companies, as well as the broader implications for patient safety across Swiss and international healthcare.
A disturbing scandal in Swiss heart surgery has sent shockwaves through the nation's esteemed medical community. The initial investigation into Zurich University Hospital (USZ) has uncovered a grim reality: years of subpar treatment led to the deaths of approximately seventy patients, with eleven particularly egregious cases prompting legal action. The probe, which cost the hospital a hefty 2 million Swiss francs, paints a picture of negligence and potentially unnecessary procedures involving novel implants.
The investigation report accused the once-celebrated surgeon Francesco Maisano of senseless implants and increased mortality rates in Zurich.
What began as a scandal localized to Zurich has now spread, implicating other major Swiss hospitals. Bern's Inselspital, for instance, finds itself under scrutiny for its use of the Cardioband device, a prosthetic ring for heart valves, which was implanted 36 times. This expansion of the investigation raises serious questions about the extent of the problem and the oversight mechanisms within Switzerland's decentralized healthcare system.
The expert group delivered for this amount the detailed chronology of one of the biggest health scandals in Swiss history.
Adding to the gravity of the situation are suspicions of financial impropriety. The central figure, surgeon Francesco Maisano, was reportedly involved with numerous medical companies. While the initial investigation did not delve deeply into these potential conflicts of interest, the NZZ am Sonntag's reporting suggests a broader pattern of concern that extends beyond Zurich. The use of the Cardioband, even in hospitals like Lucerne's Kantonsspital and internationally in Milan and Münster, raises alarms for patients and their families, highlighting a critical need for greater transparency and accountability in medical device implantation and surgical practices.
The expert group did not investigate possible financial flows around Maisano, who was involved in numerous medical companies.
DistantNews Editorial
Originally published by Neue Zürcher Zeitung in German. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
